Cargando…
Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R
Tuberous sclerosis complex (TSC) is a multisystem disease associated with hyperactive mTORC1. The impact of TSC1/2 deficiency on lysosome-mediated processes is not fully understood. We report here that inhibition of lysosomal function using chloroquine (CQ) upregulates cholesterol homeostasis genes...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503518/ https://www.ncbi.nlm.nih.gov/pubmed/28498820 http://dx.doi.org/10.18632/oncotarget.17485 |
_version_ | 1783249113371901952 |
---|---|
author | Filippakis, Harilaos Alesi, Nicola Ogorek, Barbara Nijmeh, Julie Khabibullin, Damir Gutierrez, Catherine Valvezan, Alexander J. Cunningham, James Priolo, Carmen Henske, Elizabeth P. |
author_facet | Filippakis, Harilaos Alesi, Nicola Ogorek, Barbara Nijmeh, Julie Khabibullin, Damir Gutierrez, Catherine Valvezan, Alexander J. Cunningham, James Priolo, Carmen Henske, Elizabeth P. |
author_sort | Filippakis, Harilaos |
collection | PubMed |
description | Tuberous sclerosis complex (TSC) is a multisystem disease associated with hyperactive mTORC1. The impact of TSC1/2 deficiency on lysosome-mediated processes is not fully understood. We report here that inhibition of lysosomal function using chloroquine (CQ) upregulates cholesterol homeostasis genes in TSC2-deficient cells. This TSC2-dependent transcriptional signature is associated with increased accumulation and intracellular levels of both total cholesterol and cholesterol esters. Unexpectedly, engaging this CQ-induced cholesterol uptake pathway together with inhibition of de novo cholesterol synthesis allows survival of TSC2-deficient, but not TSC2-expressing cells. The underlying mechanism of TSC2-deficient cell survival is dependent on exogenous cholesterol uptake via LDL-R, and endosomal trafficking mediated by Vps34. Simultaneous inhibition of lysosomal and endosomal trafficking inhibits uptake of esterified cholesterol and cell growth in TSC2-deficient, but not TSC2-expressing cells, highlighting the TSC-dependent lysosome-mediated regulation of cholesterol homeostasis and pointing toward the translational potential of these pathways for the therapy of TSC. |
format | Online Article Text |
id | pubmed-5503518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-55035182017-07-11 Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R Filippakis, Harilaos Alesi, Nicola Ogorek, Barbara Nijmeh, Julie Khabibullin, Damir Gutierrez, Catherine Valvezan, Alexander J. Cunningham, James Priolo, Carmen Henske, Elizabeth P. Oncotarget Priority Research Paper Tuberous sclerosis complex (TSC) is a multisystem disease associated with hyperactive mTORC1. The impact of TSC1/2 deficiency on lysosome-mediated processes is not fully understood. We report here that inhibition of lysosomal function using chloroquine (CQ) upregulates cholesterol homeostasis genes in TSC2-deficient cells. This TSC2-dependent transcriptional signature is associated with increased accumulation and intracellular levels of both total cholesterol and cholesterol esters. Unexpectedly, engaging this CQ-induced cholesterol uptake pathway together with inhibition of de novo cholesterol synthesis allows survival of TSC2-deficient, but not TSC2-expressing cells. The underlying mechanism of TSC2-deficient cell survival is dependent on exogenous cholesterol uptake via LDL-R, and endosomal trafficking mediated by Vps34. Simultaneous inhibition of lysosomal and endosomal trafficking inhibits uptake of esterified cholesterol and cell growth in TSC2-deficient, but not TSC2-expressing cells, highlighting the TSC-dependent lysosome-mediated regulation of cholesterol homeostasis and pointing toward the translational potential of these pathways for the therapy of TSC. Impact Journals LLC 2017-04-27 /pmc/articles/PMC5503518/ /pubmed/28498820 http://dx.doi.org/10.18632/oncotarget.17485 Text en Copyright: © 2017 Filippakis et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Priority Research Paper Filippakis, Harilaos Alesi, Nicola Ogorek, Barbara Nijmeh, Julie Khabibullin, Damir Gutierrez, Catherine Valvezan, Alexander J. Cunningham, James Priolo, Carmen Henske, Elizabeth P. Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R |
title | Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R |
title_full | Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R |
title_fullStr | Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R |
title_full_unstemmed | Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R |
title_short | Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R |
title_sort | lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via npc1 and ldl-r |
topic | Priority Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503518/ https://www.ncbi.nlm.nih.gov/pubmed/28498820 http://dx.doi.org/10.18632/oncotarget.17485 |
work_keys_str_mv | AT filippakisharilaos lysosomalregulationofcholesterolhomeostasisintuberoussclerosiscomplexismediatedvianpc1andldlr AT alesinicola lysosomalregulationofcholesterolhomeostasisintuberoussclerosiscomplexismediatedvianpc1andldlr AT ogorekbarbara lysosomalregulationofcholesterolhomeostasisintuberoussclerosiscomplexismediatedvianpc1andldlr AT nijmehjulie lysosomalregulationofcholesterolhomeostasisintuberoussclerosiscomplexismediatedvianpc1andldlr AT khabibullindamir lysosomalregulationofcholesterolhomeostasisintuberoussclerosiscomplexismediatedvianpc1andldlr AT gutierrezcatherine lysosomalregulationofcholesterolhomeostasisintuberoussclerosiscomplexismediatedvianpc1andldlr AT valvezanalexanderj lysosomalregulationofcholesterolhomeostasisintuberoussclerosiscomplexismediatedvianpc1andldlr AT cunninghamjames lysosomalregulationofcholesterolhomeostasisintuberoussclerosiscomplexismediatedvianpc1andldlr AT priolocarmen lysosomalregulationofcholesterolhomeostasisintuberoussclerosiscomplexismediatedvianpc1andldlr AT henskeelizabethp lysosomalregulationofcholesterolhomeostasisintuberoussclerosiscomplexismediatedvianpc1andldlr |